Dr. Jennifer Ann Adrissi, MD

Dr. Adrissi practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Adrissi's NPI, 1851782783, was assigned on February 13, 2015. Dr. Adrissi graduated from Feinberg School of Medicine in 2016. Dr. Adrissi holds California license A182650.

Dr. Adrissi's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Adrissi's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Adrissi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Adrissi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adrissi practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Adrissi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Adrissi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Adrissi's licenses on file in 2 states: California and Illinois.

Dmand AI lists parkinson's disease among the conditions Dr. Adrissi treats.

CMS data shows 42 Medicare services from Dr. Adrissi across 1 procedure code in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $6,165 for them. Every service was in an office.

CMS counts 31 Medicare patients who saw Dr. Adrissi in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 35% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adrissi's median patient age at 69, with 60% women.

In 2024, Dr. Adrissi wrote 193 Medicare Part D claims for 34 patients. 85% of them were for generic drugs. CMS names the drug for 133 of them, across 5 drugs with 11 or more claims each, at $49,246 in total drug cost. In 2023, CMS named 124 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Adrissi for performance year 2024, reported as part of a group. Dr. Adrissi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Adrissi as offering telehealth.

Dmand AI links 1 paper to Dr. Adrissi.

CMS Open Payments shows 13 general payments to Dr. Adrissi from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 54% of the total. Baxter Healthcare paid the most, $700.

Dr. Adrissi graduated from Feinberg School of Medicine in 2016.

Dr. Adrissi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.